Multiple Endocrine Neoplasia type 1 (MEN1)

The provided sources explore the diagnosis, genetic basis, and multi-modal treatment of Multiple Endocrine Neoplasia type 1 (MEN1) and related conditions. Academic reviews and clinical guidelines highlight the role of the MEN1 gene in developing tumors within the parathyroid, pancreas, and pituitary glands, while emphasizing the importance of long-term surveillance. Medical research compares various surgical interventions, such as subtotal versus total parathyroidectomy, and discusses the efficacy of novel pharmacotherapies like somatostatin analogues and menin inhibitors. Additionally, several reports focus on the psychological impact of the syndrome, noting that genetic counselling and proximity to specialised care can significantly improve a patient's quality of life. Advanced functional imaging techniques, including PET/CT scans, are also identified as critical tools for early detection and managing neuroendocrine tumors. Together, these texts offer a comprehensive overview of the clinical challenges and emerging therapeutic advancements in hereditary endocrine disorders.